Correlation Between HTG Molecular and LumiraDx

Can any of the company-specific risk be diversified away by investing in both HTG Molecular and LumiraDx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HTG Molecular and LumiraDx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HTG Molecular Diagnostics and LumiraDx, you can compare the effects of market volatilities on HTG Molecular and LumiraDx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HTG Molecular with a short position of LumiraDx. Check out your portfolio center. Please also check ongoing floating volatility patterns of HTG Molecular and LumiraDx.

Diversification Opportunities for HTG Molecular and LumiraDx

0.0

Correlation Coefficient

HTG Molecular  LumiraDx

Pay attention - limited upside

The 3 months correlation between HTG and LumiraDx is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding HTG Molecular Diagnostics and LumiraDx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LumiraDx and HTG Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HTG Molecular Diagnostics are associated (or correlated) with LumiraDx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LumiraDx has no effect on the direction of HTG Molecular i.e., HTG Molecular and LumiraDx go up and down completely randomly.

Pair Corralation between HTG Molecular and LumiraDx

If you would invest (100.00) in LumiraDx on December 28, 2024 and sell it today you would earn a total of  100.00  from holding LumiraDx or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

HTG Molecular Diagnostics  vs.  LumiraDx

HTG Molecular Diagnostics

Risk-Adjusted Performance

Very Weak

Over the last 90 days HTG Molecular Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, HTG Molecular is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

LumiraDx

Risk-Adjusted Performance

Very Weak

Over the last 90 days LumiraDx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, LumiraDx is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with HTG Molecular and LumiraDx

The main advantage of trading using opposite HTG Molecular and LumiraDx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HTG Molecular position performs unexpectedly, LumiraDx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LumiraDx will offset losses from the drop in LumiraDx's long position.

The idea behind HTG Molecular Diagnostics and LumiraDx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.